| Study ID | Study follow‐up (months) | BBV152 (n) | Placebo (n) | Important outcomes | ||
| GMT of specific antibody against 2019 novel coronavirus | GMT of neutralizing antibody against 2019 novel coronavirus | Local reactogenicity events | ||||
|
Ella 2021a (NCT04471519) |
6.38 | 100 | 75 | * | * | ✓ |
| Ella 2021b (NCT04641481) | 12 | 12,889 | 12,889 | * | * | ✓ |
|
Ella 2021a (NCT04471519) |
3.87 | 190 | 190 | * | * | ✓ |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.